Zacks Research Downgrades Definitive Healthcare (NASDAQ:DH) to Strong Sell

Definitive Healthcare (NASDAQ:DH) was downgraded by analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued to investors on Thursday,Zacks.com reports.

DH has been the subject of several other research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Definitive Healthcare in a research report on Wednesday, January 21st. Morgan Stanley restated an “underperform” rating and issued a $3.50 price objective on shares of Definitive Healthcare in a research report on Thursday, December 18th. William Blair upgraded Definitive Healthcare to a “strong-buy” rating in a research report on Thursday, November 6th. Stephens reduced their target price on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating on the stock in a research note on Friday, February 27th. Finally, Wall Street Zen lowered Definitive Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, February 28th. One research analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have issued a Hold rating and four have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and a consensus price target of $3.52.

Definitive Healthcare Trading Down 3.3%

DH opened at $1.18 on Thursday. The company has a quick ratio of 1.64, a current ratio of 1.64 and a debt-to-equity ratio of 0.41. The business has a 50 day moving average of $2.04 and a 200-day moving average of $2.79. The stock has a market cap of $166.80 million, a PE ratio of -0.94 and a beta of 1.66. Definitive Healthcare has a 52 week low of $1.07 and a 52 week high of $4.70.

Institutional Trading of Definitive Healthcare

A number of institutional investors have recently made changes to their positions in DH. State of Alaska Department of Revenue raised its position in shares of Definitive Healthcare by 109.3% in the 4th quarter. State of Alaska Department of Revenue now owns 11,433 shares of the company’s stock valued at $32,000 after purchasing an additional 5,970 shares during the last quarter. Raymond James Financial Inc. acquired a new position in shares of Definitive Healthcare in the second quarter valued at about $32,000. Schonfeld Strategic Advisors LLC acquired a new stake in Definitive Healthcare during the 4th quarter valued at approximately $35,000. Savant Capital LLC acquired a new stake in shares of Definitive Healthcare in the second quarter worth $45,000. Finally, SG Americas Securities LLC acquired a new position in shares of Definitive Healthcare in the 4th quarter valued at about $46,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.